. 2019 Feb 4;7(1):1574541. doi: 10.1080/20016689.2019.1574541
© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1.
Meta-analysis results for rivaroxaban versus VKA.